wintrymix.png
Monday January 17th, 2022 1:41AM
12:00AM ( 1 hour ago ) News Alert

Biden picks former FDA chief Califf to again lead agency

By The Associated Press
Related Articles
  Contact Editor

WASHINGTON (AP) — President Joe Biden on Friday is tapping former Food and Drug Administration commissioner Robert Califf to again lead the powerful regulatory agency, according to a person familiar with the decision.

Califf's nomination comes after months of the concern that the agency near the center of the government’s COVID-19 response has lacked a permanent leader. More than a half-dozen names were floated for the job before the White House settled on Califf.

Biden is to make the formal announcement later Friday, said the person familiar, who spoke on the condition of anonymity to preview the announcement.

A cardiologist and clinical trial specialist, Califf served as FDA commissioner for the last 11 months of President Barack Obama's second term. Before that, he spent one year as the agency's No. 2 official after more than 35 years as a researcher at Duke University, where he helped design studies for many of the world's biggest drugmakers.

Since leaving the government, he has worked as a policy adviser to tech giant Google, in addition to his ongoing work at the Duke Clinical Research Institute.

If confirmed by the Senate, Califf would oversee decisions on COVID-19 vaccines along with a raft of other knotty issues, including the regulation of electronic cigarettes and effectiveness standards for prescription drugs. He would be the first FDA commissioner since the 1940s to return for a second stint leading the agency.

“Rob is a relatively safe choice because he is known in Washington and is widely respected,” said Wayne Pines, a former FDA associate commissioner who has helped several commissioners through the confirmation process. “He will have broad support from FDA stakeholders.”

The FDA regulates the vaccines, drugs and tests used to combat COVID-19. That’s on top of its normal duties regulating a swath of consumers goods and medicines, including prescription drugs, medical devices, tobacco products, cosmetics and most foods.

Dr. Janet Woodcock, the agency’s longtime drug director, has been serving as acting commissioner since January. For months she was expected to be tapped for the permanent post, but her nomination ran into pushback from key Democratic lawmakers over the handling of opioid prescription painkillers during her 30-plus years at the agency.

The White House faced a legal deadline of mid-November to a nominate a permanent commissioner or name another acting commissioner.

Califf arrived at the FDA in 2015 determined to modernize how the agency reviewed drug and device study data. But his brief time as commissioner was dominated by unrelated pharmaceutical controversies, including the surging epidemic of opioid addiction and overdoses.

He was among the first FDA officials to publicly acknowledge missteps in the agency’s oversight of painkillers like OxyContin, which is widely blamed for sparking the ongoing opioid epidemic, which is now driven by heroin and fentanyl.

“If addiction to opioids and misuse of opioids is an enemy then we at the FDA — like every other part of society — underestimated the tenacity of the enemy,” Califf told The Associated Press in a 2016 interview. “So we’ve got to adjust.”

Califf’s extensive work with the drug industry drew scrutiny during his 2016 Senate confirmation hearing, though he was ultimately confirmed by an overwhelming margin. Given the pressing need for a permanent commissioner, he is expected to again win bipartisan confirmation. He also has the backing of the powerful pharmaceutical and medical device lobbying groups in Washington.

FDA watchers said Califf had several key advantages over other candidates vetted for the job.

“He knows how the FDA works and he avoided making any outrageous decisions as commissioner,” said Diana Zuckerman of the non-profit National Center for Health Research. “Those are essential if the FDA is going to regain the public trust.”

His first tasks would include easing burnout and boosting morale among FDA’s 18,000 employees. The agency’s medical reviewers have been straining for months under a crushing pandemic workload, while the agency’s reputation for scientific independence has been battered by a string of public controversies.

Two congressional committees are investigating the agency’s June approval of the much-debated Alzheimer’s drug, Aduhelm, against the recommendation of its outside experts, three of whom resigned over the decision. Then in September, two top FDA vaccine regulators announced they would leave the agency after disagreeing with the Biden administration plan to make COVID-19 vaccines boosters widely available.

In recent weeks the FDA has authorized extra doses of all three COVID-19 vaccines for certain groups, though not as broadly as Biden originally proposed. Pfizer has recently applied to expand eligibility for its booster to all adults, a request the FDA is expected to grant.

The latest FDA troubles followed months of turmoil between the agency and the White House under former President Donald Trump, who falsely accused the agency of deliberately slowing its review of COVID-19 vaccines to sway the presidential election.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

  • Associated Categories: Associated Press (AP), AP National News, AP Online National News, AP Online Headlines - Washington, AP Health, AP Business
© Copyright 2022 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
The Latest: Island nations press case as COP26 winds down
U.S. climate envoy John Kerry and European Commission climate official Frans Timmermans have huddled for about an hour with diplomats of island nations whose survival is threatened by rising oceans
9:06AM ( 10 minutes ago )
Turkey halts flights for some Mideast citizens to EU's door
Turkey has halted airline ticket sales to Iraqi, Syrian and Yemeni citizens wanting to travel to Belarus, which in recent months has became a key step for migrants and refugees trying to illegally enter the European Union
8:57AM ( 19 minutes ago )
France: Alleged rape at presidential palace investigated
French authorities are investigating an alleged rape that occurred earlier this year in the presidential Elysee Palace
8:55AM ( 20 minutes ago )
Associated Press (AP)
All Czech students to be tested to curb surge in virus cases
The Czech government is requiring children to get tested for COVID-19 as part of efforts to curtail a recent steep rise in cases
6:23AM ( 2 hours ago )
Japan adding more hospital beds in plan for next virus surge
Japan’s preparations for the next coronavirus surge include adding thousands more hospital beds to avoid a situation like last summer when many COVID-19 patients were forced to stay home, even when they needed supplemental oxygen
4:40AM ( 4 hours ago )
Not out of the woods: COVID cases rising in Western Europe
Nearly two years into a global health crisis that has killed more than 5 million people, infections are again sweeping across parts of Western Europe
2:19AM ( 6 hours ago )
AP Health
Johnson & Johnson to split into two companies
Johnson & Johnson is splitting into two companies, separating the division that sells Band-Aids and Listerine, from its medical device and prescription drug business
7:10AM ( 2 hours ago )
Johnson & Johnson plans to split into two companies
Johnson & Johnson is splitting into two companies, separating the division that sells Band-Aids and Listerine, from its medical device and prescription drug business
6:57AM ( 2 hours ago )
Chinese shoppers spend $139 billion during Singles' Day fest
Chinese shoppers spent $139.1 billion during this year’s annual Singles’ Day shopping extravaganza, breaking last year’s record even though consumer spending slowed amid economic uncertainty during the coronavirus pandemic
5:40AM ( 3 hours ago )
AP Business
The Latest: Island nations press case as COP26 winds down
U.S. climate envoy John Kerry and European Commission climate official Frans Timmermans have huddled for about an hour with diplomats of island nations whose survival is threatened by rising oceans
9:06AM ( 11 minutes ago )
Turkey halts flights for some Mideast citizens to EU's door
Turkey has halted airline ticket sales to Iraqi, Syrian and Yemeni citizens wanting to travel to Belarus, which in recent months has became a key step for migrants and refugees trying to illegally enter the European Union
8:57AM ( 20 minutes ago )
France: Alleged rape at presidential palace investigated
French authorities are investigating an alleged rape that occurred earlier this year in the presidential Elysee Palace
8:55AM ( 21 minutes ago )
Disease center urges Germans to cancel or avoid big events
Germany’s disease control center is calling for people to cancel or avoid large events and to reduce their contacts as the country’s coronavirus infection rate hits the latest in a string of new highs
8:47AM ( 29 minutes ago )
Climate talks soften stance on fossil fuel phaseout
Negotiators at this year’s U.N. climate talks in Glasgow appeared to be backing away from a call to end all use of coal and phase out fossil fuel subsidies completely
8:32AM ( 45 minutes ago )